UnitedHealth Group Incorporated $UNH Shares Bought by Kentucky Retirement Systems

Kentucky Retirement Systems lifted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 45.5% during the first quarter, HoldingsChannel.com reports. The fund owned 83,119 shares of the healthcare conglomerate’s stock after purchasing an additional 25,986 shares during the quarter. UnitedHealth Group makes up 0.8% of Kentucky Retirement Systems’ holdings, making the stock its 27th largest position. Kentucky Retirement Systems’ holdings in UnitedHealth Group were worth $22,491,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently bought and sold shares of UNH. Norges Bank purchased a new stake in UnitedHealth Group during the 4th quarter valued at approximately $4,376,167,000. T. Rowe Price Investment Management Inc. lifted its holdings in shares of UnitedHealth Group by 141.9% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 4,109,029 shares of the healthcare conglomerate’s stock worth $1,356,432,000 after purchasing an additional 2,410,128 shares during the period. Cardano Risk Management B.V. raised its position in UnitedHealth Group by 864.4% during the 4th quarter. Cardano Risk Management B.V. now owns 2,523,700 shares of the healthcare conglomerate’s stock worth $833,099,000 after buying an additional 2,262,006 shares during the last quarter. Hsbc Holdings PLC raised its holdings in UnitedHealth Group by 87.5% during the fourth quarter. Hsbc Holdings PLC now owns 3,916,041 shares of the healthcare conglomerate’s stock worth $1,294,367,000 after purchasing an additional 1,826,948 shares in the last quarter. Finally, Lone Pine Capital LLC purchased a new stake in shares of UnitedHealth Group in the second quarter valued at approximately $528,273,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

Key Headlines Impacting UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UnitedHealth reported second-quarter revenue of $112.03 billion and net income of $5.48 billion, while earnings per share of $6.38 exceeded the $4.94 consensus estimate. Management also raised its 2026 earnings outlook to $19.50–$20.00 per share. How Investors Are Reacting To UnitedHealth Group Profit Beat, Outlook Hike and Ongoing Buybacks
• Positive Sentiment: Lower medical costs, tighter expense control and continued share repurchases are strengthening the investment case and signaling that UnitedHealth’s profitability recovery is gaining traction. Analysts and market commentators have highlighted UNH as a blue-chip buying opportunity following the earnings beat. UnitedHealth’s Cost-Control Story is Gaining Momentum Buy These 3 Blue-Chip Stocks After Strong Q2 2026 Earnings Results
• Positive Sentiment: UnitedHealth’s shares have rallied significantly since their March low, and the earnings beat has prompted renewed debate over whether the stock remains undervalued after its recovery. UnitedHealth Earnings Spark Fresh Value Debate
• Neutral Sentiment: UnitedHealth committed $4 million, alongside technical support, to help expand UT Health Sciences’ health-hub network in Tennessee from five to 13 locations. The initiative may improve community access and brand reputation but is unlikely to materially affect near-term earnings. UnitedHealth Partners with UT Health Sciences
• Negative Sentiment: Some investors question the durability of the improved medical loss ratio because part of the benefit came from exiting unprofitable markets rather than broad-based operating improvement. Technical commentary also warns that the sharp rally could face consolidation. UnitedHealth Group Stock Opinions on Q2 Earnings Beat
• Negative Sentiment: Humana’s elevated medical cost ratio and decision to reaffirm rather than raise its forecast create a cautious read-through for managed-care companies, keeping pressure on investors to monitor utilization and healthcare-cost trends. Why Humana Stock Is Falling After Earnings Beat Expectations

Analyst Upgrades and Downgrades

Several research analysts have weighed in on UNH shares. Erste Group Bank upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Monday, April 27th. Oppenheimer upped their target price on UnitedHealth Group from $420.00 to $500.00 and gave the company an “outperform” rating in a report on Friday, July 17th. Robert W. Baird upgraded shares of UnitedHealth Group from an “underperform” rating to a “neutral” rating and raised their target price for the company from $287.00 to $453.00 in a report on Thursday, July 16th. Morgan Stanley upped their target price on UnitedHealth Group from $468.00 to $529.00 and gave the company an “overweight” rating in a research note on Friday, July 17th. Finally, Royal Bank Of Canada upped their target price on shares of UnitedHealth Group from $463.00 to $478.00 and gave the company an “outperform” rating in a report on Friday, July 17th. Two research analysts have rated the stock with a Strong Buy rating, twenty have given a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat.com, UnitedHealth Group has an average rating of “Moderate Buy” and an average target price of $455.92.

UnitedHealth Group Trading Down 1.7%

NYSE UNH opened at $421.30 on Thursday. The company has a 50-day moving average of $410.08 and a 200-day moving average of $347.25. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.78 and a quick ratio of 0.80. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $461.62. The company has a market cap of $382.60 billion, a P/E ratio of 27.11, a P/E/G ratio of 1.49 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.94 by $1.44. The firm had revenue of $112.03 billion during the quarter, compared to the consensus estimate of $110.81 billion. UnitedHealth Group had a net margin of 3.14% and a return on equity of 16.53%. UnitedHealth Group’s revenue was up .4% compared to the same quarter last year. During the same period in the previous year, the firm earned $4.08 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. As a group, equities analysts predict that UnitedHealth Group Incorporated will post 19.69 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 23rd. Stockholders of record on Monday, June 15th were issued a $2.32 dividend. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $2.21. The ex-dividend date was Monday, June 15th. This represents a $9.28 dividend on an annualized basis and a dividend yield of 2.2%. UnitedHealth Group’s dividend payout ratio (DPR) is 59.72%.

UnitedHealth Group Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.